Teva Pharms Inc patent expiration
1. Alvaiz patent expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US11072586 | TEVA PHARMS INC | Solid state forms of eltrombopag choline |
Nov, 2038
(14 years from now) | |
Drugs and Companies using ELTROMBOPAG CHOLINE ingredient
Market Authorisation Date: 29 November, 2023
Treatment: Treatment of adult patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy
Dosage: TABLET
More Information on Dosage
ALVAIZ family patents
